Reversal of protumour activity of T lymphocytes could be achieved by the development of a methodology to suppport the transformation of CD4+ T cells toward Th1 cells, hence reinforcing the activation and infiltration of CD8+ T cells into the tumour microenvironment of HCC [107]. The gene discussed is CD4; the disease is neoplasm.